Clinical Trial Update: Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance [Phase 2]

View source ↗

Summary

Phase 2 trial updating the impact of JJVC senofilcon A contact lens with a new UV-blocker on day and night driving performance; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visual Performance

Drugs mentioned

• JJVC senofilcon A contact lens with new UV-blocker (senofilcon A with UV-blocker)

Snippet

Sponsor: Johnson & Johnson Vision Care, Inc. | Conditions: Visual Performance | Phase 2 | Status: COMPLETED | Results posted: 2018-08-07